Education
About Us
Working with TipRanks
Follow Us
GlucoTrack (GCTK)
NASDAQ:GCTK
GCTK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.11 - $3,756.00
Previous Close$0.14
Volume195.77M
Average Volume (3M)1.84M
Market Cap
$4.21M
Enterprise Value-$5.96M
Total Cash (Recent Filing)$9.10M
Total Debt (Recent Filing)$52.00K
Price to Earnings (P/E)―
Beta1.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-68.06
Shares Outstanding567,456
10 Day Avg. Volume2,269,407
30 Day Avg. Volume1,837,318
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.27
Price to Sales (P/S)0.00
P/FCF Ratio-0.24
Enterprise Value/Market Cap-1.41
Enterprise Value/Revenue-70.90
Enterprise Value/Gross Profit744.42
Enterprise Value/Ebitda0.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GlucoTrack News
PremiumCompany Announcements
GlucoTrack Completes Major Warrant Repurchase
PremiumCompany Announcements
GlucoTrack Announces Positive Clinical Study Results
Options Prices
Currently, No data available
---
Ownership Overview
25.79% Insiders
<0.01%
Mutual Funds
0.18% Other Institutional Investors
74.02% Public Companies and Individual Investors
GCTK FAQ
What was GlucoTrack’s price range in the past 12 months?
GlucoTrack lowest stock price was $5.11 and its highest was $3756.00 in the past 12 months.
What is GlucoTrack’s market cap?
GlucoTrack’s market cap is $4.21M.
When is GlucoTrack’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GlucoTrack’s earnings last quarter?
Currently, no data Available
Is GlucoTrack overvalued?
According to Wall Street analysts GlucoTrack’s price is currently Overvalued.
Does GlucoTrack pay dividends?
GlucoTrack does not currently pay dividends.
What is GlucoTrack’s EPS estimate?
GlucoTrack’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GlucoTrack have?
GlucoTrack has 567,456 shares outstanding.
What happened to GlucoTrack’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GlucoTrack?
Currently, no hedge funds are holding shares in GCTK
GlucoTrack Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Positive
Last 7 Days ▲ 10.6%
Last 30 Days ▲ 19.7%
Last 30 Days ▲ 19.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.56%
12-Months-Change
Fundamentals
Return on Equity
-694.34%
Trailing 12-Months
Asset Growth
356.41%
Trailing 12-Months
Company Description
GlucoTrack
GlucoTrack (GCTK) is a medical technology company specializing in the development and commercialization of innovative glucose monitoring devices. The company focuses on providing non-invasive solutions for individuals managing diabetes, aiming to enhance their quality of life through advanced technology. GlucoTrack's core product is a non-invasive glucose measurement device designed to offer an alternative to traditional finger-stick testing, thus providing a more comfortable and convenient monitoring experience for users.
Technical Analysis
Milestone Scientific
―
Predictive Oncology
―
Femasys
―
Meihua International Medical Technologies Co., Ltd.
―